219 related articles for article (PubMed ID: 16849682)
1. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
2. ABERRANT METHYLATION OF CANCER-RELATED GENES IN VIETNAMESE BREAST CANCER PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
Dieu Vuong L; Ngoc Nguyen Q
Exp Oncol; 2023 Oct; 45(2):195-202. PubMed ID: 37824772
[TBL] [Abstract][Full Text] [Related]
3. Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population.
Zhao Y; Guo S; Sun J; Huang Z; Zhu T; Zhang H; Gu J; He Y; Wang W; Ma K; Wang J; Yu J
PLoS One; 2012; 7(4):e35175. PubMed ID: 22529986
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Putluri N; Shojaie A; Vasu VT; Vareed SK; Nalluri S; Putluri V; Thangjam GS; Panzitt K; Tallman CT; Butler C; Sana TR; Fischer SM; Sica G; Brat DJ; Shi H; Palapattu GS; Lotan Y; Weizer AZ; Terris MK; Shariat SF; Michailidis G; Sreekumar A
Cancer Res; 2011 Dec; 71(24):7376-86. PubMed ID: 21990318
[TBL] [Abstract][Full Text] [Related]
5. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
[TBL] [Abstract][Full Text] [Related]
6. Novel urine-based DNA methylation biomarkers for urothelial bladder carcinoma detection in patients with hematuria.
Abol-Elnazer HF; Awadalla A; Ahmed AE; Abol-Enein H; Al Ganzouri MA; Elsawy AA
Arab J Urol; 2023; 21(4):248-257. PubMed ID: 38178946
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer.
Jiang YH; Liu YS; Wei YC; Jhang JF; Kuo HC; Huang HH; Chan MWY; Lin GL; Cheng WC; Lin SC; Wang HJ
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472940
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide DNA Methylation in Prediagnostic Blood and Bladder Cancer Risk in the Women's Health Initiative.
Jordahl KM; Randolph TW; Song X; Sather CL; Tinker LF; Phipps AI; Kelsey KT; White E; Bhatti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):689-695. PubMed ID: 29540343
[No Abstract] [Full Text] [Related]
9. Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis (MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a Four-Stage Pipeline of Modern Machine Learning Techniques.
Reynolds T; Riddick G; Meyers G; Gordon M; Flores Monar GV; Moon D; Moon C
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203643
[TBL] [Abstract][Full Text] [Related]
10. A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.
Salta S; P Nunes S; Fontes-Sousa M; Lopes P; Freitas M; Caldas M; Antunes L; Castro F; Antunes P; Palma de Sousa S; Henrique R; Jerónimo C
J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30405052
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis for ovarian cancer detection in patient-friendly samples.
Wever BMM; Schaafsma M; Bleeker MCG; van den Burgt Y; van den Helder R; Lok CAR; Dijk F; van der Pol Y; Mouliere F; Moldovan N; van Trommel NE; Steenbergen RDM
Commun Med (Lond); 2024 May; 4(1):88. PubMed ID: 38755429
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancer.
Pavan N; Scaggiante B
Front Oncol; 2024; 14():1391466. PubMed ID: 38496760
[No Abstract] [Full Text] [Related]
13. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.
Chung W; Bondaruk J; Jelinek J; Lotan Y; Liang S; Czerniak B; Issa JP
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1483-91. PubMed ID: 21586619
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.
Reinert T; Modin C; Castano FM; Lamy P; Wojdacz TK; Hansen LL; Wiuf C; Borre M; Dyrskjøt L; Orntoft TF
Clin Cancer Res; 2011 Sep; 17(17):5582-92. PubMed ID: 21788354
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-based biomarkers in bladder cancer.
Kandimalla R; van Tilborg AA; Zwarthoff EC
Nat Rev Urol; 2013 Jun; 10(6):327-35. PubMed ID: 23628807
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
[TBL] [Abstract][Full Text] [Related]
17. Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: a prospective, two-center validation study.
Vinci S; Giannarini G; Selli C; Kuncova J; Villari D; Valent F; Orlando C
Urol Oncol; 2011; 29(2):150-6. PubMed ID: 19272801
[TBL] [Abstract][Full Text] [Related]
18. High Detection Rate for Non-Muscle-Invasive Bladder Cancer Using an Approved DNA Methylation Signature Test.
Steinbach D; Kaufmann M; Hippe J; Gajda M; Grimm MO
Clin Genitourin Cancer; 2020 Jun; 18(3):210-221. PubMed ID: 32139301
[TBL] [Abstract][Full Text] [Related]
19. Liquid-based biomarkers in breast cancer: looking beyond the blood.
Shuai Y; Ma Z; Ju J; Wei T; Gao S; Kang Y; Yang Z; Wang X; Yue J; Yuan P
J Transl Med; 2023 Nov; 21(1):809. PubMed ID: 37957623
[TBL] [Abstract][Full Text] [Related]
20. High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
Inokawa Y; Hayashi M; Begum S; Noordhuis MG; Sidransky D; Califano J; Koch W; Brait M; Westra WH; Hoque MO
BMC Cancer; 2022 Nov; 22(1):1146. PubMed ID: 36344942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
